Skip to content

NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest (ARISE)

A Feasibility Study of the NEURESCUE Device as an Adjunct to In-Hospital Cardiac Arrest

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05444049
Acronym
ARISE
Enrollment
6
Registered
2022-07-05
Start date
2022-12-08
Completion date
2024-09-30
Last updated
2025-10-09

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiac Arrest, Cardiopulmonary Arrest, Cardiovascular Diseases

Brief summary

The NEURESCUE device is the first intelligent catheter for aortic balloon occlusion, an emergency technique that supercharges blood flow to the heart and brain within one minute from deployment. The catheter-based device is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body. The objective of this study is to investigate the feasibility of the NEURESCUE device as an adjunct to Advanced Cardiac Life Support (ACLS) in adults with cardiac arrest.

Interventions

The balloon catheter is delivered via the femoral artery, temporarily inflating a soft balloon in the descending aorta to redirect blood flow towards the upper body.

Sponsors

neurescue
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

1. Age ≥18 and ≤80 years 2. CPR initiated within 7 min of presumed arrest 3. 8 min of continuous ACLS without ROSC

Exclusion criteria

1. Traumatic cardiac arrest 2. Intraoperative cardiac arrest 3. Known pregnancy 4. Known terminal disease 5. Known do-not-attempt-CPR order 6. Subjects whose femoral arterial access site cannot accommodate an 8 Fr introducer sheath 7. Subjects currently on mechanical circulatory support

Design outcomes

Primary

MeasureTime frame
Successful balloon inflation within 10 minutes from first vessel punctureAssessed up to 10 min

Secondary

MeasureTime frameDescription
Change in central blood pressureAssessed up to 1 hour
Total ACLS time at initiation of the investigational procedureAssessed up to 1 hour
Time from first vessel puncture to successful sheath insertionAssessed up to 1 hour
Rate of occlusion successAssessed up to 1 hour
Return of spontaneous circulation (ROSC)Assessed up to 1 hourThe endpoint is dichotomous (yes/no) for each subject

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026